chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Onset of gastritis within 1 day of receiving 2nd dose of vaccine; Migraine; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration on the left arm on 28Apr2021 at 13:45(at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included GERD, migraine, depression and anxiety.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included rizatriptan (MANUFACTURER UNKNOWN), sertraline (MANUFACTURER UNKNOWN), vitamin d nos (VITAMIN D) and vitamin b complex (MANUFACTURER UNKNOWN). The patient previously took doxycycline (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. The patient previously took BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration on the left arm on 07Apr2021 at 12:45 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Apr2021 at 13:00 the patient experienced onset of gastritis within 1 day of receiving 2nd dose of vaccine as well as 4 migraines from 04/28/21 to 05/01/21. The patient had a history of gastritis and migraines but she not had an episode of gastritis since 2019 and her migraines were usually not this frequent. The patient went to an urgent care walk in clinic on 04/29/21 for gastritis and received a GI cocktail for her symptoms. She was now recovering and treating gastritis with anti acids along with an adjusted diet for GERD and taking her usually prescribed medicine for migraines (rizatriptan 10mg) as needed. She was not sure if it was related to the vaccine but she thought that she should report it anyway. The event resulted in doctor or other healthcare professional office/clinic visit and also in emergency room/department or urgent care. Therapeutic measures were taken as a result of gastritis and migraine and included treatment with GI cocktail and continued use of migraine medicine (rizatriptan 10mg). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event onset of gastritis within 1 day of receiving 2nd dose of vaccine and migraine was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Child developed local reaction to flu vaccine beginning the following morning after injection. Reaction site increased in size to "baseball" size on deltoid. No symptoms of abscess. Child brought to office on third day after injection.  Follow up 10/25/2001: "Child had no other vaccines at this visit.  No other vaccines in prevous 4 weeks, on no medication, no history of previous adverse events."
Patient did not have any reactions or report any symptoms. However, patient is 14 years of age but was administered a child's dose (Pfizer covid-19 age 5 to <12 years of age) instead of the adult dose. Per CDC guidelines, re-vaccinating will not be necessary.
Vaccine was administered very high in my right shoulder on 6/17/16. Extreme pained and stiffness of my shoulder joint ensued within 2 hours. Given a course of oral steroids and a muscle relaxer on 6/29/16. Pain and stiffness briefly improved, but returned after treatment. Seen by orthopedic physician 8/3/16 and treated with a steroid injection, scheduled for physical therapy.
Pt was brought to the ER due to altered mental status and combative behavior. COVID was positive, however pt was nonhypoxic. Pt was admitted for acute hypoxic encephalopathy, COVID-19, hypomagnesemia and hyponatremia, and an immunocompromised state.
One week after the shot (Saturday the 16th) my injection site had developed a red hot circle. Over the news few days it faded slightly and grew in size. It was slightly itchy. Still sore. Now (Jan 22) it has faded quite a bit. Still sore.
fever - 101 degF duration 14 hrs; lethargic, joint pain; injection site - red, swollen, hot to touch, muscle aches; *has had this 5 times in the past with no negative side effects*
5 minutes after administering vaccine. Staff member complained of tingling, hot flushed face and nausea. Benadryl 50mg given. After 45 minutes staff member had no symptoms and was sent home with a friend. Instructed to contact her medical doctor.
Afterwards I didn't notice anything, but if I touched the area or put my arm in a certain position, then i would notice sensitivity or discomfort.; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Afterwards I didn't notice anything, but if I touched the area or put my arm in a certain position, then i would notice sensitivity or discomfort.) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced LIMB DISCOMFORT (Afterwards I didn't notice anything, but if I touched the area or put my arm in a certain position, then i would notice sensitivity or discomfort.). At the time of the report, LIMB DISCOMFORT (Afterwards I didn't notice anything, but if I touched the area or put my arm in a certain position, then i would notice sensitivity or discomfort.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided.  No treatment information was provided.
Excruciating shoulder pain in Left shoulder. (opposite arm from injection site.) Lasting 3 days. Seven days later, (Friday  Feb 19) excruciating pain in opposite (RIGHT)shoulder. Lasting approximately 3 days with gradual improvement. Seven days after that,  (Friday Feb 26) pain in LEFT shoulder again. Also began having random joint pain in different areas of my body: middle toes of both feet, soles of feet, knees, fingers, hands along with extreme fatigue, body aches and general malaise, lack of energy. I am still experiencing fatigue, lack of energy and random joint pain.
Heart pain/ inflammation; Heart pain/ inflammation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult male patient received bnt162b2 (BNT162B2), intramuscular, administration date 17Jan2022 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: Sep2021 (unspecified if ongoing); "heart pain" (unspecified if ongoing); "heart pain diagnosed as inflammation" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 2), for Covid-19 immunization; Bnt162b2 (Dose 1), for Covid-19 immunization. The following information was reported: ANGINA PECTORIS (medically significant), MYOCARDITIS (medically significant) all with onset 18Jan2022, outcome "recovering" and all described as "Heart pain/ inflammation". Therapeutic measures were not taken as a result of angina pectoris, myocarditis. It was reported the patient had contracted COVID in Sep2021 and experienced heart pain that was diagnosed as inflammation caused by the virus. The person had not experienced this side effect with the first two doses. The third dose triggered heart pain/inflammation. No hospitalization was required. The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient presented to emergency department on 9/28/2021 due to altered mental status and hyponatremia. Patient was found to be COVID-19 positive during screening for hospital admission. He was asymptomatic for COVID-19 infection during admission and required no treatment for symptoms.
PT and mother agreed to receive vaccine in left arm. Immediately after the needle was in his arm, and during administration of vaccine, pt jerked his arm back and pulled away. Majority of vaccine did not make it into pt's muscle, but on his skin. Pt also bent the needle after he pulled away. A employee was immediately notified of incident, who contacted her supervisor. The supervisor gave the go ahead to have the vaccine administered in the opposite arm. Pt's mother agreed to have her son receive the vaccine in the other arm. Mother held the pt more closely to her. Vaccine was successfully administered in the right arm with no incident.
The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.; The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.; No adverse event; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT AVAILABILITY ISSUE (The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.), PRODUCT ADMINISTRATION INTERRUPTED (The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.) and NO ADVERSE EVENT (No adverse event) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Feb-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT AVAILABILITY ISSUE (The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.), PRODUCT ADMINISTRATION INTERRUPTED (The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT AVAILABILITY ISSUE (The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.), PRODUCT ADMINISTRATION INTERRUPTED (The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT AVAILABILITY ISSUE (The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.) and PRODUCT ADMINISTRATION INTERRUPTED (The patient states that her 17-year-old daughter received the first primary dose of Moderna on 23Feb2023. She's been trying for 2 hours to schedule her daughter's second dose.).    Concomitant medication was not provided.   Treatment information was not provided.   Reporter did not allow further contact
Appendicitis. Symptoms started on Nov. 9. Had appendectomy on Nov 11.
1/14/21 - Resident complained of SOB. SPO2 66% on RA, vs 105/66-96-20 T98.2 O2 administered Pox 97% Binax test revealed (+) COVID results. Resident transferred to COVID wing. Family (HCP) updated and declined transfer to hospital Resident continued with fever, hypoxia and lethargy. Family elected CMO and Hospice notified. Resident died on 1/16/2021 @ 930AM.
RIGHT upper extremity with an area of erythema measuring ~3"x 4" on the lateralwith an extension a streak of erythema extending up to axilla . The area is warm to touch and has tenderness to palpation. NO pustules, purulent drainage, fluctuance. cephalexin (KEFLEX) 500 mg capsule; Take 1 capsule (500 mg total) by mouth 4 (four) times a day for 7 days. Please take the antibiotics (CEPHALEXIN) as directed. Elevate the arm frequently and minimize use. Keep the area of infection clean and dry. You can take a shower or bath, but be sure to pat the area dry with a towel afterward. Do not put any antibiotic ointments or creams on the area.
mild pain at injection site; mild body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "mild pain at injection site"; PAIN (non-serious), outcome "unknown", described as "mild body aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Client received the vaccine on 3/30. She started having symptoms on 4/2. (Vomiting, diarrhea, bad cough). She believed that she was getting better, then on 4/12, she went to the hospital due to cough, shortness of breath with exertion, diarrhea, fever decreased appetite, headaches, intermittent wheezing and chills. She was admitted for oxygen therapy and further assessment. She had a positive Covid test on 4/4.
pt recv vax 27FEB96 & w/in 24 hr the morning of 28FEB96 pt exp a h/a which was severe enough to leave work;also exp achiness;
Moderna COVID-19 Vaccine EUA Nausea, weakness, fatigue, chills, fever (102), dizziness, headache, pain at the injection site, body aches. Adverse affects began 13 hours after injection and lasted 36 hours. Treatment: bedrest and anti-vomiting medication.
Golf ball sized swollen, red, hot to touch, area at site of injection.  Very painful to touch. This area has doubled in size overnight. Also, lymph nodes under that arm are swollen and I cannot even hold that arm against my side without feeling them.
Mild fever; Injection site pain; Feeling a little unwell; This is a spontaneous report from a non-contactable consumer (patient). A 52-year-old male patient received their first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: 1284, expiry date not reported), via an unspecified route of administration on the left arm on 13Jan2021 14:00 at single dose for COVID-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing (COVID prior to vaccination). There were no concomitant medications.  The patient experienced mild fever on second day, injection site pain, feeling a little unwell; all unspecified dates. The outcome of the events was unknown. The patient was not covid tested post vaccination.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Currently pregnant. Estimated delivery date: 1/17/2022. First baby. On the night after receiving booster shot, a lump formed at shot site. The lump is about 2 in diameter and extremely itchy. Tried Benadryl cream( does not help), calamine lotion( relief s a bit), ice pack on shoulder( helps a lot). The symptom continues and don?t know when will it recover.
2 DAYS AFTER VACCINATION RED RASH, PUSTULES AND BOILS DEVELOPED AT AND AROUND THE VACCINATION SITE
fast heartbeat; kind of dizzy; A spontaneous report was received from a consumer who was a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fast heartbeat and was kind of dizzy earlier.  The patient's medical history was not provided. Concomitant medications reported included tamoxifen.  On 04 Jan 2021, the patient received her first of two planned doses of mRNA-1273 (Lot number: not reported) for prophylaxis of COVID-19 infection.  On the same day, the patient experienced a fast heartbeat and was kind of dizzy earlier. The patient mentioned that she has been taking tamoxifen for 4.5 years and enquired if this concomitant medication was causing the side effects.    No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, fast heartbeat and kind of dizzy was not reported.; Reporter's Comments: This case concerns a female patient of unknown age, who experienced non-serious unexpected events of Heart rate increased and Dizziness. The events occurred on the same date after first dose of mRNA-1273, lot # unknown. Treatment details were not provided.  Based on the current available information and temporal association between the use of the product and onset of the events a causal relationship cannot be excluded.
Within five minutes I felt very faint and dizzy along with nausea. Then came the shortness of breath and the feeling of pins and needles which also brought itching and some minor hives with it. The dizziness, nausea, and feeling of fainting went away after about 10 minutes and I had to go to the Emergency Department to take care of the shortness of breath and hive like reaction. I was given some medications and they diagnosed it as a moderate allergic reaction to the vaccine. I was completely fine with the first one.
fever ( 101.0) body aches, nausea and vomiting treating with home supportive care/ ibuprofen and tylenol
Pain/ache in heart area for around 72 hours, lessening and then ending. Heart seems to be working fine (can run 8K in about the same time as before vaccination). Did not affect daily activities, except didn't run until pain was gone. No treatment except refraining from running.
Severe back pain from the lumbar spine through the thoracic spine. Small movements cause sharp pain. From the day after my booster till present.
diagnosed with Pneumonia; sick; tested positive for the COVID19 virus; tested positive for the COVID19 virus; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's wife) reported that a 53-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15Apr2021 (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunization.  The patient medical history and concomitant medications were not reported.  The patient got sick and had been hospitalized and had been diagnosed with Pneumonia. Also, reported patient ended up in the hospital because he got pneumonia. The patient tested positive for the COVID19 virus. The events outcome was unknown. Information on the lot/batch number has been requested.
Arm swelling, itching, stiffness. Was given antibiotic injections and oral antibiotics.
At site of immunization (R deltoid), 5 cm area induration, no erythema.  (Examined 12/19/2007, reaction began evening of immunization 12/17/07).
Swollen clavicular lymph node, arm soreness, body aches.  Taking tylenol and motrin for arm soreness and body aches with improvement.
Moderna COVID-19 Vaccine EUA  adverse affect to the sun- legs itchy and extremely red/purple  8 days after sun exposure
Rash on arm where vaccine was administered. Itched, hurt and warm to the touch. Tylenol and Benadryl used first day but didn?t seem to help very much.  Still have same amount of redness but itching and soreness have lessened.
This case was reported by a healthcare professional and described the occurrence of rash in a 57-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). No other vaccines were given on the same date. There were no significant allergies or any history of any reaction to a vaccine before. On 28 April 2014, the subject received an unspecified dose of BOOSTRIX (administration site and route unknown). On 28 April 2014, 5 to 10 minutes after vaccination with BOOSTRIX, the subject experienced a rash on her upper chest. The subject was treated with BENADRYL. At the time of reporting, the outcome of the event was unspecified.
Neurologist said I'm having an autoimmune response to the vaccine; Shortness of breath started one month after the second shot; followed by chest tightness (ER visit 1); A slew of other neurological symptoms began (apx 30) including sharp chest pain; neurological symptoms; This was followed by muscles seizing up in my back and neck to the point where I could not turn my head and it was affecting my tongue and speech (ER visit 3); This was followed by muscles seizing up in my back and neck to the point where I could not turn my head and it was affecting my tongue and speech (ER visit 3); This is a spontaneous report from a contactable consumer (patient) via a Covid-19 program  A 40-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm left on 26Apr2021 07:45 (lot number: EW0165; expiry date: unknown) as dose 2, single, for COVID-19 immunisation. Medical history included COVID and pneumonia. She possibly had a long COVID starting with all of the COVID symptoms on 02Dec2019. She had to take 6 weeks of medical leave from work to recover from pneumonia, symptoms lasted 4-6 months. Concomitant medications included ibuprofen (ADVIL), ethinylestradiol, etonogestrel (NUVARING), and nasal sprays for allergies. The patient previously received first dose of BNT162B2 on 05Apr2021 at 07:45 AM (lot number: EW0151; expiry date: unknown) at the age of 40-years-old, in left arm for COVID-19 immunisation.The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 28May2021, the patient experienced shortness of breath that started one month after the second shot, followed by chest tightness (ER visit 1). Did chest X-ray and CT chest scan. A slew of other neurological symptoms began (apx 30) including sharp chest pain to go with the shortness of breath (ER visit 2). Did chest X-ray and follow up CT scan. This was followed by muscles seizing up in my back and neck to the point where she could not turn her head and it was affecting her tongue and speech (ER visit 3). At this point, it had been two months of rotating neurological symptoms, so the doctor admitted her to the hospital to run a CT scan on her carotid artery and MRI of the brain. Through all of these she had tons of blood tests done and an echocardiogram done looking for autoimmune diseases. None were found. Spoke to a rheumatologist who referred her to pulmonologist and neurologist. Pulmonologist will test her for asthma this fall, but nothing was clear. Neurologist said she was having an autoimmune response to the vaccine. The patient was hospitalized due to the events for one day. Outcome of the events was recovering.
This spontaneous report was received from a nurse concerning a patient of unknown gender and age. The patient's pertinent medical history and concurrent conditions were not provided. On an unspecified date between 03-AUG-2015 and 06-AUG-2015, the patient was vaccinated with an unspecified dose of (Oka/Merck) VARIVAX immunization series that was improperly stored (Lot # L005299, expiration date: 17-FEB-2017) (dose and route not provided). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Chest pain and shortness of breath.  working diagnosis: pleuritis  has history of mild COVID infection: diagnosed with COVID via PCR on 12/12/2020 and recovered.  Hospitalized at Medical Center from 02/8/2021 to 02/09/2021.